NCT06051240View on ClinicalTrials.gov

Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2033

Conditions
Cognitive ImpairmentCognitive DeclineRadiotherapy Side EffectRadiotherapy; ComplicationsBrain TumorMemory ImpairmentLate Effect of Radiation
Interventions
DRUG

Lithium

Lithium sulphate, 42 mg (6 mmol lithium)

DRUG

Placebo

White round tablet, 10 mm. Identical to experimental drug (lithium)

Trial Locations (2)

17176

RECRUITING

HOPE, Stockholm

171 64

NOT_YET_RECRUITING

Karolinska Universitetssjukhuset, Solna

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Region Stockholm

OTHER_GOV